The Matter at Hand: A Case of Difficult‐to‐Treat Arthritis
Click on the article title to read more.
Related Articles
Achieving Medication‐Free Remission in Patients With Juvenile Dermatomyositis
Objective Prognostic factors associated with medication discontinuation in children with juvenile dermatomyositis (JDM) remain largely elusive. We aim to identify the predictors of medication-free r…
Extensor Tendon Repair
Extensor tendon injuries are a common condition that hand surgeons must be prepared to treat. The area of extensor tendon injury can traditionally be broken…
Best of 2024: Consensus Statements on Vitamin D | RheumNow
The “Controversies in Vitamin D” International Conference has published their proceedings on vitamin D metabolism, assessment, actions, and supplementation. Interestingly, optimal levels of 25-hydroxy vitamin…
Temporal Trends of Improvement After Minimally Invasive… : Spine
ignificantly after MIS TLIF, evidence regarding the temporal trends in improvement is still largely lacking. Methods. Patients who underwent primary single-level MIS TLIF for degenerative…
The MSK playbook: Tennis elbow – BJSM blog – social media’s leading SEM voice
Tennis elbow (or lateral epicondylitis) is a common upper limb condition seen in the musculoskeletal (MSK) clinic. It can cause significant pain, restriction to activity…
IRF1 deficiency predisposes cartilage to accumulate DNA damage and promotes osteoarthritis development
Objective Interferon regulatory factor 1 (IRF1) is a transcriptional regulator conventionally associated with immunomodulation. Recent molecular analyses mapping DNA binding sites of IRF1 have sugge…
Current Trends in Ultramarathon Running : Current Sports Medicine Reports
ditional challenges in race performance and medical coverage for these events. As the sport grows in popularity, more literature has become available regarding ultramarathon-specific illnesses…
Comparative Risk of Gout Flares When Initiating or Escalating Various Urate‐Lowering Therapy: A Systematic Review With Network Meta‐Analysis
Objective We systematically examined comparative gout flare risk after initiation or escalation of different urate-lowering therapies (ULTs), comparative flare risk with and without concomitant flar…
State-of-the Art-Clinical Symposium
At the State-of-the-Art Clinical Symposium key opinion leaders will deliver a range of content on therapeutic developments, recent research findings, and scientific advancements.
EULAR 2025 – Abstracts
EULAR invites you to submit an abstract to EULAR 2025, the European Congress of Rheumatology. Every year EULAR invites abstract submitters from all over the…
